|
1
|
Should adolescents with acute lymphoblastic leukemia be treated as old children or young adults? Comparison of the French FRALLE-93 and LALA-94 trials.
|
J Clin Oncol
|
2003
|
2.15
|
|
2
|
Rituximab therapy for childhood Evans syndrome.
|
Haematologica
|
2007
|
1.33
|
|
3
|
Prognostic factors for leukemic induction failure in children with acute lymphoblastic leukemia and outcome after salvage therapy: the FRALLE 93 study.
|
J Clin Oncol
|
2008
|
1.32
|
|
4
|
Results of induction chemotherapy in children older than 1 year with a stage 4 neuroblastoma treated with the NB 97 French Society of Pediatric Oncology (SFOP) protocol.
|
J Clin Oncol
|
2005
|
1.13
|
|
5
|
Further delineation of the congenital form of X-linked dyskeratosis congenita (Hoyeraal-Hreidarsson syndrome).
|
Eur J Pediatr
|
2003
|
1.11
|
|
6
|
Outcome in children with relapsed acute myeloid leukemia after initial treatment with the French Leucemie Aique Myeloide Enfant (LAME) 89/91 protocol of the French Society of Pediatric Hematology and Immunology.
|
J Clin Oncol
|
2003
|
1.09
|
|
7
|
Road traffic and childhood leukemia: the ESCALE study (SFCE).
|
Environ Health Perspect
|
2010
|
1.03
|
|
8
|
Excellent prognosis of late relapses of ETV6/RUNX1-positive childhood acute lymphoblastic leukemia: lessons from the FRALLE 93 protocol.
|
Haematologica
|
2012
|
0.93
|
|
9
|
Impact of genotype on survival of children with T-cell acute lymphoblastic leukemia treated according to the French protocol FRALLE-93: the effect of TLX3/HOX11L2 gene expression on outcome.
|
Haematologica
|
2008
|
0.91
|
|
10
|
An investigation of the steady-state pharmacokinetics of oral valacyclovir in immunocompromised children.
|
J Infect Dis
|
2002
|
0.90
|
|
11
|
Treatment outcome after low intensity chemotherapy [CVP] in children and adolescents with early stage nodular lymphocyte predominant Hodgkin's lymphoma - an Anglo-French collaborative report.
|
Eur J Cancer
|
2011
|
0.85
|
|
12
|
Familial history of cancer and childhood acute leukemia: a French population-based case-control study.
|
Eur J Cancer Prev
|
2007
|
0.83
|
|
13
|
Ectopic Cushing's syndrome due to an adrenal ganglioneuroma.
|
Horm Res Paediatr
|
2010
|
0.79
|
|
14
|
Vaccination and the risk of childhood acute leukaemia: the ESCALE study (SFCE).
|
Int J Epidemiol
|
2007
|
0.78
|
|
15
|
Comparative values of catecholamines and metabolites for the diagnosis of neuroblastoma.
|
Eur J Pediatr
|
2003
|
0.77
|
|
16
|
Outcome of children and adolescents with recurrent/refractory classical Hodgkin lymphoma, a study from the Société Française de Lutte contre le Cancer des Enfants et des Adolescents (SFCE).
|
Br J Haematol
|
2012
|
0.77
|
|
17
|
A 22-year French experience with solid tumors in children with Down syndrome.
|
Pediatr Hematol Oncol
|
2003
|
0.76
|
|
18
|
Impact of age, leukocyte count and day 21-bone marrow response to chemotherapy on the long-term outcome of children with philadelphia chromosome-positive acute lymphoblastic leukemia in the pre-imatinib era: results of the FRALLE 93 study.
|
BMC Cancer
|
2009
|
0.75
|
|
19
|
Paediatric anaplastic large cell lymphoma with leukaemic presentation in children: a report of nine French cases.
|
Br J Haematol
|
2014
|
0.75
|
|
20
|
A dose-intensive approach (NB96) for induction therapy utilizing sequential high-dose chemotherapy and stem cell rescue in high-risk neuroblastoma in children over 1 year of age.
|
Pediatr Blood Cancer
|
2011
|
0.75
|
|
21
|
A 1-Year Prospective French Nationwide Study of Emergency Hospital Admissions in Children and Adults with Primary Immunodeficiency.
|
J Clin Immunol
|
2019
|
0.75
|
|
22
|
Economic evaluation of recombinant human granulocyte colony-stimulating factor in very high-risk childhood acute lymphoblastic leukemia.
|
J Pediatr Hematol Oncol
|
2003
|
0.75
|
|
23
|
Identification of a complex 17q rearrangement in a metanephric stromal tumor.
|
Cancer Genet
|
2011
|
0.75
|